Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijid.2020.07.014 http://scihub22266oqcxt.onion/10.1016/j.ijid.2020.07.014 32663601!7836996!32663601     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Infect+Dis 2020 ; 99 (ä): 100-101 Nephropedia Template TP {{tp|p=32663601|t=2020. Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge |pdf=|usr=}}{{32663601}} gab.com Text Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge JO: Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32663601 #FOAvip OBJECTIVE: To assess the degree of hypoxia and subjective dyspnea elicited by a 6-minute walking test (6MWT) in COVID-19 patients prior to discharge. METHODS: A 6MWT was performed in 26 discharge-ready COVID-19 patients without chronic pulmonary disease or cardiac failure. Heart rate, oxyhemoglobin saturation (SpO(2)), respiratory rate, and subjective dyspnea measured on the Borg CR-10 scale were measured before and immediately after the 6MWT, with continuous monitoring of SpO(2) and heart rate during the 6MWT. The 6MWT was terminated if SpO(2) dropped below 90%. A historical cohort of 204 patients with idiopathic pulmonary fibrosis (IPF) was used for comparison. RESULTS: 13 (50%) of the COVID-19 patients developed exercise-induced hypoxia (SpO(2) < 90%) during the 6MWT, of which one third had pulmonary embolism. COVID-19 patients experienced less hypoxia-related dyspnea during the 6MWT compared with patients with IPF. CONCLUSION: The 6MWT is a potential tool in the diagnosis of asymptomatic exercise-induced hypoxia in hospitalized COVID-19 patients prior to discharge. Due to important methodological limitations, further studies are needed to confirm our findings and to investigate their clinical consequences. Twit Text FOAVip Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge ????Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32663601 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32663601 #FOAvip English Wikipedia <ref>{{Cite pmid|32663601}}</ref> Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge #MMPMID32663601 Fuglebjerg NJU; Jensen TO; Hoyer N; Ryrso CK; Lindegaard B; Harboe ZB Int J Infect Dis 2020[Oct]; 99 (ä): 100-101 PMID32663601show ga OBJECTIVE: To assess the degree of hypoxia and subjective dyspnea elicited by a 6-minute walking test (6MWT) in COVID-19 patients prior to discharge. METHODS: A 6MWT was performed in 26 discharge-ready COVID-19 patients without chronic pulmonary disease or cardiac failure. Heart rate, oxyhemoglobin saturation (SpO(2)), respiratory rate, and subjective dyspnea measured on the Borg CR-10 scale were measured before and immediately after the 6MWT, with continuous monitoring of SpO(2) and heart rate during the 6MWT. The 6MWT was terminated if SpO(2) dropped below 90%. A historical cohort of 204 patients with idiopathic pulmonary fibrosis (IPF) was used for comparison. RESULTS: 13 (50%) of the COVID-19 patients developed exercise-induced hypoxia (SpO(2) < 90%) during the 6MWT, of which one third had pulmonary embolism. COVID-19 patients experienced less hypoxia-related dyspnea during the 6MWT compared with patients with IPF. CONCLUSION: The 6MWT is a potential tool in the diagnosis of asymptomatic exercise-induced hypoxia in hospitalized COVID-19 patients prior to discharge. Due to important methodological limitations, further studies are needed to confirm our findings and to investigate their clinical consequences. |*Betacoronavirus[MESH] |*Patient Discharge[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications[MESH] |Exercise Test[MESH] |Humans[MESH] |Hypoxia/*diagnosis/*etiology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications[MESH]Silent hypoxia in patients with SARS CoV-2 infection before hospital d(epmc).pdf DeepDyve Pubget Overpricing